NuCelle's SunSense SPF30+ Among Forbes Magazine's Top 10 Nanotech Products of 2003

Share Article

The main ingredient of NuCelle's sunscreen, SunSense SPF30+, is Z-COTE, a substance made with nano-technology which enables it to go on clear - unlike most zinc-based sunscreens - and makes it effective against both UVA as well as UVB rays.

North American Medical Services Inc. (TSXV: NMI) (“NAMS”) is pleased to provide its shareholders with the following update.

NAMS wholly owned subsidiary NuCèlle Inc. is proud to announce that NuCèlle’s SunSense SPF30+ sunscreen has been named to Forbes Magazine's list of Top 10 Nanotech Products for 2003. An excerpt from that article appears below:

Adviser Soapbox

The Top Ten Nanotech Products Of 2003

Robert Paull, The Forbes/Wolfe Nanotech Report, 12.29.03, 12:16 PM ET

Don't miss the Nanotech Revolution! Forbes/Wolfe's Weekly Nanotech Insider will keep you up to date on the latest developments in this exciting new science. Sign up today. It's free:

8) Nanocrystalline Sunscreen

Whether you're heading to the islands or the slopes this winter, you may want to slather on a bottle of NuCelle SunSense SPF 30 sunscreen. Its main ingredient is Z-COTE, a substance made with nanotechnology by BASF (nyse: BF - news - people). "Nano-dispersed zinc oxide is the basis of Z-COTE," says BASF's Dieter Distler. The common SPF (sun protection factor) rating system only rates protection against UVB rays. Zinc oxide provides broad-spectrum protection against UVA and UVB rays, but its characteristic white pasty goop often leaves sunbathers and lifeguards feeling like they're wearing clown makeup. The nanotechnology in Z-Cote produces a high-purity nanocrystalline zinc oxide, which allows the sunscreen to go on clear. And, to boot, the inorganic Z-COTE can't be absorbed by the skin and won't cause allergic reactions.

For more information:


“Deborah Fortescue-Merrin”

Deborah Fortescue-Merrin


Contact: Deborah Fortescue-Merrin

Telephone: (604) 947-2555

The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Deborah Fortescue-Merrin
Visit website